Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 51 shares at $186.78 ($10K) on 2021-11-15, disclosed to the SEC on 2021-11-16.
Scheduled sale ($10k) by EVP, Chief Patient Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.78 | 21 | $4K | 41.1% |
| 2 | $187.48 | 30 | $6K | 58.9% |
| Total | $187.19 avg | 51 | $10K | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |